Clinical Development Support
Ferring Pharmaceuticals · Ferríng Pharmaceuticals
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Clinical Development Support as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:43 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03067597 · An Open-label Trial Investigating the Efficacy and Safety of a Vaginal Insert in Pregnant Women at TermFerring Pharmaceuticals · completed · Cervical Ripening · study director
- Ph3NCT03067727 · A Randomised Trial Investigating the Efficacy and Safety of a Vaginal Insert in Pregnant Women at TermFerring Pharmaceuticals · completed · Cervical Ripening · study director
- Ph3NCT03051009 · Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese SubjectsFerring Pharmaceuticals · completed · Nocturia · study director
- Ph3NCT03017235 · A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for ColonoscopyFerring Pharmaceuticals · completed · Bowel Preparation · study director
- N/ANCT02935335 · A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur®Ferring Pharmaceuticals · completed · Infertility · study director
- N/ANCT02835469 · A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With InfertilityFerring Pharmaceuticals · completed · Infertility · study director
- N/ANCT02790281 · A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel DiseaseFerring Pharmaceuticals · completed · Inflammatory Bowel Disease · study director
- Ph3NCT02526784 · A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2/Ph3NCT02508649 · Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical TrialFerring Pharmaceuticals · terminated · Septic Shock · study director
- Ph1NCT02468284 · Pharmacokinetics of Degarelix in Chinese Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph3NCT02449889 · A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian StimulationFerring Pharmaceuticals · completed · Infertility · study director
- Ph2NCT02392546 · Elobixibat Colonic Motor Function StudyFerring Pharmaceuticals · withdrawn · Chronic Idiopathic Constipation · study director
- Ph4NCT02386449 · A Study Comparing Picoprep With Mannitol and Bisacodyl for Colon Cleansing in Preparation for ColonoscopyFerring Pharmaceuticals · completed · Bowel Preparation · study director
- N/ANCT02368743 · QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)Ferring Pharmaceuticals · completed · Distal Ulcerative Colitis · study director
- N/ANCT02368730 · Documentation of the Efficacy of Desmopressin Within the Context of Surgical ProceduresFerring Pharmaceuticals · completed · Platelet Dysfunction · study director
- Ph3NCT02368717 · An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension PhaseFerring Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph2NCT02309671 · A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) TreatmentFerring Pharmaceuticals · completed · Infertility · study director
- N/ANCT02242214 · REgistry of MisOprostol 200 µg Vaginal dElivery SystemFerring Pharmaceuticals · completed · Induction of Labour · study director
- Ph3NCT02239692 · A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for ColonoscopyFerring Pharmaceuticals · completed · Bowel Cleansing · study director
- N/ANCT02229253 · Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate CancerFerring Pharmaceuticals · completed · Advanced Hormone Sensitive Prostate Cancer · study director
- Ph3NCT02215954 · A Phase III Study With FE 999169 Versus Niflec for Colon CleansingFerring Pharmaceuticals · completed · Colon Cleansing in Preparation for Colonoscopy · study director
- Ph3NCT02173821 · A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone DeficiencyFerring Pharmaceuticals · completed · Idiopathic Growth Hormone Deficiency · study director
- Ph3NCT02149264 · A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal MalesFerring Pharmaceuticals · completed · Adult Male Hypogonadism · study director
- N/ANCT02018172 · Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X DeviceFerring Pharmaceuticals · terminated · Growth Hormone Deficiency, Turner's Syndrome · study director
- N/ANCT02018159 · An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human EmbryosFerring Pharmaceuticals · completed · Infertility · study director
- Ph3NCT02015871 · An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2NCT01968187 · Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi SyndromeFerring Pharmaceuticals · completed · Hyperphagia in Prader-Willi Syndrome · study director
- Ph3NCT01956110 · Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1Ferring Pharmaceuticals · completed · Infertility · study director
- Ph3NCT01956123 · Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2Ferring Pharmaceuticals · completed · Infertility · study director
- Ph1/Ph2NCT01928862 · Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for ColonoscopyFerring Pharmaceuticals · completed · Need for Bowel Preparation · study director
- Ph3NCT01923194 · Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese FemalesFerring Pharmaceuticals · completed · Anovulation · study director
- Ph3NCT01922193 · Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) ProgramFerring Pharmaceuticals · completed · Infertility · study director
- Ph3NCT01895543 · Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic ConstipationFerring Pharmaceuticals · completed · Chronic Idiopathic Constipation · study director
- N/ANCT01861236 · Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in ArgentinaFerring Pharmaceuticals · completed · Advanced Hormone Dependent Prostate Cancer · study director
- Ph3NCT01833065 · Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic ConstipationFerring Pharmaceuticals · terminated · Chronic Idiopathic Constipation · study director
- Ph3NCT01827592 · 26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic ConstipationFerring Pharmaceuticals · terminated · Chronic Idiopathic Constipation · study director
- Ph2NCT01779466 · Daytime Impact Sleep StudyFerring Pharmaceuticals · terminated · Nocturia · study director
- N/ANCT01748591 · Monitoring of Safety and Tolerance of PICOPREP in Clinical PracticeFerring Pharmaceuticals · terminated · Bowel Cleanliness · study director
- Ph3NCT01744366 · One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese PopulationFerring Pharmaceuticals · completed · Prostate Cancer · study director
- N/ANCT01731028 · Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®Ferring Pharmaceuticals · withdrawn · Growth Hormone Deficiency · study director
- N/ANCT01729676 · Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy InitiationFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2NCT01729819 · Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in WomenFerring Pharmaceuticals · completed · Overactive Bladder · study director
- Ph2NCT01723982 · Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine ContractionsFerring Pharmaceuticals · completed · Infertility · study director
- Ph3NCT01710514 · A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility TreatmentFerring Pharmaceuticals · completed · Luteal Hormone Supplementation · study director
- Ph3NCT01703741 · A Multicenter Extension Trial to Evaluate the Safety of Testosterone GelFerring Pharmaceuticals · completed · Adult Male Hypogonadism · study director
- N/ANCT01703728 · Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.Ferring Pharmaceuticals · completed · Ovarian Hyperstimulation Syndrome (OHSS) · study director
- Ph2NCT01694498 · Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult MenFerring Pharmaceuticals · completed · Nocturia · study director
- Ph2NCT01684800 · Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult WomenFerring Pharmaceuticals · completed · Nocturia · study director
- N/ANCT01674894 · Study of the Cleavage of the Egg in Relation to the Stimulation TreatmentFerring Pharmaceuticals · completed · Female Infertility · study director
- Ph3NCT01665599 · A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone GelFerring Pharmaceuticals · completed · Adult Male Hypogonadism · study director
- Ph2NCT01612676 · Investigating FE 202158 as Potential Primary Treatment in Patients With Early Septic ShockFerring Pharmaceuticals · completed · Septic Shock · study director
- N/ANCT01552395 · A Study of Minirin Melt in 24 Months Treatment in Patients With NocturiaFerring Pharmaceuticals · completed · Nocturia · study director
- Ph3NCT01552343 · Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact DiaryFerring Pharmaceuticals · completed · Nocturia · study director
- N/ANCT01517607 · Mesalazine (PENTASA®) in Ulcerative ColitisFerring Pharmaceuticals · completed · Ulcerative Colitis · study director
- N/ANCT01517594 · Tolerability of Pentasa Sachet in Patients With Ulcerative ColitisFerring Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph2NCT01491971 · Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph3NCT01474499 · A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With ConstipationFerring Pharmaceuticals · completed · Constipation · study director
- Ph2NCT01464879 · A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an ApplicatorFerring Pharmaceuticals · completed · Hypogonadal Males · study director
- Ph2NCT01426386 · A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI TreatmentFerring Pharmaceuticals · completed · Infertility · study director
- Ph4NCT01417195 · Menopur Mixed ProtocolFerring Pharmaceuticals · completed · Infertility · study director
- N/ANCT01387698 · Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative ColitisFerring Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph1/Ph2NCT01373606 · A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1Ferring Pharmaceuticals · completed · Hepatorenal Syndrome Type 1 · study director
- Ph2NCT01370369 · Efficacy, Pharmacokinetics and Safety of TestosteroneFerring Pharmaceuticals · completed · Testicular Hypogonadism · study director
- N/ANCT01368913 · MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal EnuresisFerring Pharmaceuticals · completed · Nocturnal Enuresis · study director
- N/ANCT01365351 · Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTONFerring Pharmaceuticals · completed · Growth Hormone Deficiency · study director
- N/ANCT01363427 · Retrospective Data Analysis in Crohn's DiseaseFerring Pharmaceuticals · completed · Crohn's Disease · study director
- N/ANCT01363453 · User Surveillance in Ulcerative ColitisFerring Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph3NCT01356407 · Investigation of PICOPREP and PEG-ELS for Bowel Preparation for ColonoscopyFerring Pharmaceuticals · completed · Colonoscopy · study director
- N/ANCT01354834 · Assessment of the Effectiveness of Menopur in Intrauterine InseminationFerring Pharmaceuticals · completed · Infertility · study director
- N/ANCT01351818 · Adipocyte Function and Somtropin DeficiencyFerring Pharmaceuticals · completed · Growth Hormone Deficiency · study director
- Ph2NCT01335386 · Investigation of KLYX in Patients With ConstipationFerring Pharmaceuticals · completed · Constipation · study director
- N/ANCT01335516 · Follow-up of Glypressin (Terlipressin) Clinical Efficacy in the Treatment of Bleeding Oesophageal VaricesFerring Pharmaceuticals · completed · Gastrointestinal Bleeding, Oesophageal Varices · study director
- N/ANCT01331720 · Assessment of the Effectiveness and Tolerability of Ovarian HyperstimulationFerring Pharmaceuticals · completed · STERILITY · study director
- N/ANCT01331733 · Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH AntagonistFerring Pharmaceuticals · completed · Sterility · study director
- N/ANCT01330771 · Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HPFerring Pharmaceuticals · completed · Sterility · study director
- N/ANCT01330784 · Assessment of the Therapeutic Utility of hMG-HPFerring Pharmaceuticals · completed · Sterility · study director
- N/ANCT01306357 · Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free DeviceFerring Pharmaceuticals · completed · Turner's Syndrome, Human Growth Hormone Deficiency · study director
- N/ANCT01292109 · A Study of PICOPREP in Patients Needed to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery.Ferring Pharmaceuticals · completed · Bowel Cleanliness · study director
- Ph2NCT01283022 · Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)Ferring Pharmaceuticals · completed · Cervical Ripening, Induction of Labor · study director
- Ph3NCT01280981 · A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual BleedingFerring Pharmaceuticals · completed · Menorrhagia · study director
- Ph3NCT01280188 · A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).Ferring Pharmaceuticals · completed · Central Diabetes Insipidus · study director
- Ph3NCT01262456 · Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male PatientsFerring Pharmaceuticals · completed · Nocturia · study director
- Ph3NCT01242748 · A Degarelix Trial in Patients With Prostate CancerFerring Pharmaceuticals · terminated · Prostate Cancer · study director
- Ph4NCT01225835 · Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)Ferring Pharmaceuticals · completed · Infertility · study director
- Ph3NCT01223937 · Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female PatientsFerring Pharmaceuticals · completed · Nocturia · study director
- N/ANCT01222598 · A Study of Minirin Melt in Patients With NocturiaFerring Pharmaceuticals · completed · Nocturia · study director
- N/ANCT01220453 · Compliance and Efficacy in the Use of PICOPREP®Ferring Pharmaceuticals · completed · Bowel Cleanliness · study director
- Ph3NCT01220869 · A Study of Degarelix in Taiwanese Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- N/ANCT01215526 · A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph3NCT01215513 · Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean PatientsFerring Pharmaceuticals · completed · Prostate Cancer · study director
- N/ANCT01212224 · A Study of Minirin Melt in Patients With NocturiaFerring Pharmaceuticals · completed · Nocturia · study director
- N/ANCT01202123 · Post Marketing Surveillance of MENOPURFerring Pharmaceuticals · completed · Infertility · study director
- Ph4NCT01190163 · Open Label Comparative Trial of Dinoprostone Plus or Minus Oxytocin Versus Oxytocin Alone in Cervical Ripening for Labor InductionFerring Pharmaceuticals · terminated · Vaginal Delivery, Cesarean Section · study director
- Ph4NCT01190150 · Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual BleedingFerring Pharmaceuticals · completed · Menorrhagia · study director
- Ph2NCT01184859 · Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and PlaceboFerring Pharmaceuticals · completed · Nocturia · study director
- N/ANCT01148433 · Quality of Life With TESTIM®Ferring Pharmaceuticals · completed · Hypogonadism · study director
- Ph3NCT01127581 · Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal DeliveryFerring Pharmaceuticals · completed · Reducing Time to Vaginal Delivery, Cervical Ripening, Induction of Labor · study director
- N/ANCT01104753 · A Study of Pentasa in Patients With Ulcerative ColitisFerring Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph3NCT01078753 · Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal EnuresisFerring Pharmaceuticals · completed · Nocturnal Enuresis · study director
- Ph3NCT01073930 · Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Split Dose PicoPrepFerring Pharmaceuticals · completed · Bowel Preparation · study director
- Ph3NCT01073943 · Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Day Before PicoPrepFerring Pharmaceuticals · completed · Bowel Preparation · study director
- Ph3NCT01071915 · Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2NCT01043120 · Effect of Oxytocin Antagonist on Reduction of Uterine ContractionsFerring Pharmaceuticals · completed · In Vitro Fertilisation (IVF) Treatment · study director
- Ph2NCT01000649 · Effects of the V1a Agonist FE 202158 in Patients With Septic ShockFerring Pharmaceuticals · completed · Septic Shock · study director
- Ph3NCT00988091 · Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the KneeFerring Pharmaceuticals · completed · Osteoarthritis of the Knee · study director
- Ph3NCT00967018 · A Long Term Safety Study of Degarelix in Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2NCT00947882 · A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)Ferring Pharmaceuticals · completed · Lower Urinary Tract Symptoms (LUTS) · study director
- Ph3NCT00946920 · A Trial of Degarelix in Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- N/ANCT00930319 · Effectiveness and Safety of Firmagon®Ferring Pharmaceuticals · completed · Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma · study director
- Ph3NCT00928434 · A Study of Degarelix in Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2NCT00925938 · Efficacy and Safety Study of the Misoprostol Vaginal Priming Insert (MVPI) Prior to HysteroscopyFerring Pharmaceuticals · completed · Cervical Priming · study director
- N/ANCT00902265 · Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)Ferring Pharmaceuticals · completed · Nocturia Associated With Nocturnal Polyuria · study director
- Ph3NCT00884273 · Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer PatientsFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph3NCT00884000 · A Study of Zomacton in Children With Growth Hormone DeficiencyFerring Pharmaceuticals · completed · Growth Hormone Deficiency · study director
- Ph3NCT00884221 · MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo TransferFerring Pharmaceuticals · completed · Infertility · study director
- Ph3NCT00862121 · A Study With Pentasa in Patients With Active Crohn's DiseaseFerring Pharmaceuticals · terminated · Crohn´s Disease · study director
- Ph3NCT00833248 · Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph3NCT00831233 · Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate CancerFerring Pharmaceuticals · terminated · Prostate Cancer · study director
- Ph2NCT00828711 · Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of LaborFerring Pharmaceuticals · completed · Cervical Ripening, Induction of Labor · study director
- Ph2NCT00819156 · Dose Finding Trial With a New Treatment (Degarelix) for Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2NCT00818623 · Investigation of a New Trial Drug (FE200486) in Prostate Cancer PatientsFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2NCT00819247 · The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph4NCT00805935 · Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)Ferring Pharmaceuticals · completed · Polycystic Ovarian Syndrome, Infertility · study director
- Ph4NCT00802360 · MENOPUR® Versus FOLLISTIM®Ferring Pharmaceuticals · completed · Infertility · study director
- Ph3NCT00801242 · Intermittent Treatment With Degarelix of Patients Suffering From Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2NCT00796289 · Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile FemalesFerring Pharmaceuticals · completed · Infertility · study director
- Ph2NCT00738673 · Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph3NCT00737789 · Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.Ferring Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph3NCT00728533 · Open-Label, Randomised Parallel-Group StudyFerring Pharmaceuticals · withdrawn · Prostate Cancer · study director
- Ph3NCT00615836 · An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in AdultsFerring Pharmaceuticals · completed · Nocturia · study director
- Ph3NCT00603733 · Canadian Active & Maintenance Modified Pentasa StudyFerring Pharmaceuticals · completed · Active Ulcerative Colitis, Remission of Ulcerative Colitis · study director
- Ph2NCT00587327 · Effect of Oxytocin and Vasopressin Antagonists on Uterine ContractionsFerring Pharmaceuticals · completed · In Vitro Fertilisation (IVF) Treatment · study director
- Ph2NCT00527488 · Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.Ferring Pharmaceuticals · completed · BPH · study director
- Ph3NCT00477490 · Efficacy and Safety of Desmopressin Melt for the Treatment of NocturiaFerring Pharmaceuticals · completed · Nocturia · study director
- Ph2NCT00468286 · Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation TherapyFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph3NCT00451958 · A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation TherapyFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2NCT00434122 · Exploratory Study Assessing Synchronisation of Egg Sacs With DegarelixFerring Pharmaceuticals · completed · Infertility, Female · study director
- Ph2/Ph3NCT00423371 · Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMCFerring Pharmaceuticals · completed · Osteoarthritis · study director
- Ph3NCT00401193 · Efficacy and Safety of XP12B in Women With MenorrhagiaFerring Pharmaceuticals · completed · Menorrhagia, Heavy Menstrual Bleeding · study director
- Ph3NCT00386308 · Efficacy and Safety Study of XP12B in Women With MenorrhagiaFerring Pharmaceuticals · completed · Menorrhagia, Heavy Menstrual Bleeding · study director
- N/ANCT00379236 · A Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the KneeFerring Pharmaceuticals · completed · Osteoarthritis, Knee · study director
- Ph2NCT00329693 · Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of QuinagolideFerring Pharmaceuticals · completed · Ovarian Hyperstimulation Syndrome · study director
- Ph3NCT00296478 · Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)Ferring Pharmaceuticals · completed · Fertility · study director
- Ph2/Ph3NCT00296465 · A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRHFerring Pharmaceuticals · completed · InFertility · study director
- Ph3NCT00295750 · The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2/Ph3NCT00268892 · Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph4NCT00257556 · A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin AlfaFerring Pharmaceuticals · completed · Infertility · study director
- Ph3NCT00250250 · An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MGFerring Pharmaceuticals · completed · Turner's Syndrome · study director
- Ph4NCT00245479 · A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal EnuresisFerring Pharmaceuticals · completed · Nocturnal Enuresis · study director
- Ph3NCT00245505 · The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"Ferring Pharmaceuticals · terminated · Crohn's Disease · study director
- Ph2NCT00245466 · Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer PatientsFerring Pharmaceuticals · terminated · Prostate Cancer · study director
- Ph3NCT00230594 · Desmopressin Response in the YoungFerring Pharmaceuticals · completed · Primary Nocturnal Enuresis · study director
- Ph4NCT00225810 · A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s DiseaseFerring Pharmaceuticals · completed · Crohn's Disease · study director
- Ph2/Ph3NCT00215683 · An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2NCT00215657 · Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsFerring Pharmaceuticals · terminated · Prostate Cancer · study director
- Ph3NCT00209300 · Pentasa Once Daily in Ulcerative Colitis for Maintenance of RemissionFerring Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph2NCT00209326 · A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm LaborFerring Pharmaceuticals · completed · Labor, Premature, Premature Birth · study director
- Ph4NCT00209261 · A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)Ferring Pharmaceuticals · completed · Primary Nocturnal Enuresis · study director
- Ph4NCT00209287 · Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative ColitisFerring Pharmaceuticals · terminated · Ulcerative Colitis · study director
- Ph2NCT00117949 · Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486Ferring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2/Ph3NCT00117286 · Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2NCT00117312 · Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsFerring Pharmaceuticals · terminated · Prostate Cancer · study director
- Ph2NCT00116753 · A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph2NCT00116779 · A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph3NCT00113568 · Safety Study of XP12B in Women With MenorrhagiaFerring Pharmaceuticals · completed · Menorrhagia, Heavy Menstrual Bleeding · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.